BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17130525)

  • 1. The Type 1 Diabetes Genetics Consortium.
    Rich SS; Concannon P; Erlich H; Julier C; Morahan G; Nerup J; Pociot F; Todd JA
    Ann N Y Acad Sci; 2006 Oct; 1079():1-8. PubMed ID: 17130525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the Type I Diabetes Genetics Consortium.
    Rich SS; Akolkar B; Concannon P; Erlich H; Hilner JE; Julier C; Morahan G; Nerup J; Nierras C; Pociot F; Todd JA
    Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S1-4. PubMed ID: 19956093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of international consortia in studies on the pathogenesis of type 1 diabetes: the role of ET1DGN.
    Pociot F
    Diabetes Metab Res Rev; 2006; 22(3):238-40. PubMed ID: 16355419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and the future for the genetics of type I diabetes.
    Rich SS; Akolkar B; Concannon P; Erlich H; Hilner JE; Julier C; Morahan G; Nerup J; Nierras C; Pociot F; Todd JA
    Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S128-31. PubMed ID: 19956094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico replication of the genome-wide association results of the Type 1 Diabetes Genetics Consortium.
    Qu HQ; Bradfield JP; Li Q; Kim C; Frackelton E; Grant SF; Hakonarson H; Polychronakos C
    Hum Mol Genet; 2010 Jun; 19(12):2534-8. PubMed ID: 20378605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1DBase, a community web-based resource for type 1 diabetes research.
    Smink LJ; Helton EM; Healy BC; Cavnor CC; Lam AC; Flamez D; Burren OS; Wang Y; Dolman GE; Burdick DB; Everett VH; Glusman G; Laneri D; Rowen L; Schuilenburg H; Walker NM; Mychaleckyj J; Wicker LS; Eizirik DL; Todd JA; Goodman N
    Nucleic Acids Res; 2005 Jan; 33(Database issue):D544-9. PubMed ID: 15608258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes.
    Steenkiste A; Valdes AM; Feolo M; Hoffman D; Concannon P; Noble J; Schoch G; Hansen J; Helmberg W; Dorman JS; Thomson G; Pugliese A;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():214-25. PubMed ID: 17445204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes.
    Park Y
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S110-5. PubMed ID: 17448564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetics of type 1 diabetes: A comprehensive review.
    Noble JA
    J Autoimmun; 2015 Nov; 64():101-12. PubMed ID: 26272854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to autoimmune endocrine diseases.
    Caillat-Zucman S
    Ann Med Interne (Paris); 1999 Apr; 150(3):221-34. PubMed ID: 10445094
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenetics of insulin-dependent juvenile diabetes.
    Dausset J; Hors J
    Diabetes Res; 1984 Sep; 1(3):115-23. PubMed ID: 6085045
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of MYO9B haplotype with type 1 diabetes.
    Santiago JL; Martínez A; Núñez C; de la Calle H; Fernández-Arquero M; de la Concha EG; Urcelay E
    Hum Immunol; 2008 Feb; 69(2):112-5. PubMed ID: 18361936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology and genetics of type 1 diabetes.
    Morran MP; Omenn GS; Pietropaolo M
    Mt Sinai J Med; 2008 Aug; 75(4):314-27. PubMed ID: 18729178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.
    Viken MK; Blomhoff A; Olsson M; Akselsen HE; Pociot F; Nerup J; Kockum I; Cambon-Thomsen A; Thorsby E; Undlien DE; Lie BA
    Genes Immun; 2009 Jun; 10(4):323-33. PubMed ID: 19295542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility.
    Shin HD; Yang SW; Kim DH; Park Y
    Ann N Y Acad Sci; 2008 Dec; 1150():76-85. PubMed ID: 19120272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of HLA association with autoimmune diseases.
    Caillat-Zucman S
    Tissue Antigens; 2009 Jan; 73(1):1-8. PubMed ID: 19017300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).
    Hilner JE; Perdue LH; Sides EG; Pierce JJ; Wägner AM; Aldrich A; Loth A; Albret L; Wagenknecht LE; Nierras C; Akolkar B;
    Clin Trials; 2010; 7(1 Suppl):S5-S32. PubMed ID: 20603248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetes: lessons for other autoimmune diseases?
    Harrison LC; Honeyman MC; Morahan G; Wentworth JM; Elkassaby S; Colman PG; Fourlanos S
    J Autoimmun; 2008 Nov; 31(3):306-10. PubMed ID: 18558477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region.
    Kawabata Y; Ikegami H; Fujisawa T; Noso S; Asano K; Hiromine Y; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():278-84. PubMed ID: 17130566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variation within the major histocompatibility complex subregion centromeric of HLA class II in type 1 diabetes.
    van der Slik AR; van den Eng I; Eerligh P; Doxiadis II; Koeleman BP; Roep BO; Giphart MJ
    Tissue Antigens; 2007 Apr; 69(4):348-53. PubMed ID: 17389020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.